Dabigatran must be used carefully: literature review and recommendations for management of adverse events

Atrial fibrillation increases the risk of stroke and death. The vitamin-K antagonist warfarin is recommended for patients with atrial fibrillation, but vitamin-K antagonists are cumbersome to use. Therefore, an effective, safe and convenient new anticoagulant is needed. Dabigatran acts by inhibiting...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shan, Wang, Yan, Zhang, Lei, Guan, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511609/
https://www.ncbi.nlm.nih.gov/pubmed/31190734
http://dx.doi.org/10.2147/DDDT.S203112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511609/
https://www.ncbi.nlm.nih.gov/pubmed/31190734
http://dx.doi.org/10.2147/DDDT.S203112

Ejemplares similares